The table below shows Enveric Biosciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$2.78M
$2.84M
$7.25M
$8.03M
$4.79M
$174.08K
SG&A
$5.79M
ENVB annual revenue (10-K history)
Enveric Biosciences, Inc. reported annual revenue of $39.91M for fiscal year 2019. That is down 7.2% from $43.00M in fiscal 2018. Over the 7 fiscal years shown, annual revenue grew from $6.14M (FY 2014) to $39.91M. Figures come from the company's audited annual reports as filed with the SEC.